Mika Health partners with pharma giants for women’s oncology initiative

Article Analysis:

Highlights:
1. Partnership for Digital Therapeutics in Breast Cancer Treatment: Mika Health, an oncology-focused digital therapeutics company, has partnered with pharma companies AstraZeneca and Daiichi Sankyo to provide digital therapeutics to women undergoing breast cancer treatments.

2. Comprehensive Support through Mika Health’s App: The Mika Health app offers cancer patients access to psychological support to reduce anxiety, depression, and stress related to the disease. Patients can also track medication side effects, receive reminders, get education and nutrition advice, and schedule appointments.

3. Customizable Digital Therapeutic: The digital therapeutic by Mika Health, already certified as a medical device in the EU, can be personalized to an individual’s specific type of cancer, enhancing its effectiveness.

Summary:
The article discusses the partnership between Mika Health, AstraZeneca, and Daiichi Sankyo to provide digital therapeutics to women undergoing breast cancer treatments. Mika Health’s app offers a range of support services to cancer patients, and its digital therapeutic can be tailored to the individual’s specific cancer type. The collaboration aims to enhance cancer care through a holistic approach combining digital therapies with pharmaceutical treatments.

Editorial content by NewsSIP AI